MOG and ocular melanoma: A single therapeutic injection of OM-MOG increased proportions of Ly6ChiCCR2+ cells, and sharply increased MHCII production by Ly6ChiCCR2+ cells, after 24 h in PB and spleen of dpi 16 EAE mice (clinical peak) (Figures 5A, B).